Clinical trial

SGLT2 Inhibitors and Cognitive Function in Adults With Type 2 Diabetes (SaveMinD)

NCT07694596

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2026-06-20

PhaseNA

Study timeline

Study start (actual)2026-06-20Date precision: day

Registry last updated2026-07-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitus (T2DM)unresolved

Cognitive Dysfunctionunresolved

Interventions

SGLT2 InhibitorDRUG

Standard Diabetes CareOTHER

Sponsors & collaborators

University of Primorskalead sponsor

University of Ljubljana, Faculty of Medicinecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07694596 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.